A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Condition(s):Leukemia, Acute LymphoblasticLast Updated:March 19, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Leukemia, Acute LymphoblasticLast Updated:March 19, 2024Recruiting
Condition(s):ExerciseLast Updated:February 14, 2024Recruiting
Condition(s):Brain InjuriesLast Updated:January 30, 2024Recruiting
Condition(s):Community-acquired PneumoniaLast Updated:March 7, 2024Recruiting
Condition(s):Mild Cognitive Impairment; Randomized Controlled Trial; Subjective Cognitive ImpairmentLast Updated:March 13, 2024Not yet recruiting
Condition(s):Brain DeathLast Updated:March 28, 2023Recruiting
Condition(s):SepsisLast Updated:February 1, 2024Recruiting
Condition(s):Feeding DisordersLast Updated:February 12, 2024Recruiting
Condition(s):Myelodysplastic Syndrome; Recurrent Myelodysplastic Syndrome; Refractory Myelodysplastic SyndromeLast Updated:January 8, 2024Recruiting
Condition(s):Recurrent Severe Aplastic Anemia; Refractory Severe Aplastic AnemiaLast Updated:December 22, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.